ACC reconsiders stance on nonculprit lesions | Female ICs are a minority, data show | Read more from SCAI: Study finds women underrepresented in interventional cardiology field
Web Version
September 23, 2014
SCAI SmartBrief
News for Invasive/Interventional Cardiologists

Top StoriesAdvertisement
ACC reconsiders stance on nonculprit lesions
New data, including the results of the CvLPRIT and PRAMI trials, have prompted the American College of Cardiology to revoke its Choosing Wisely stance on stenting of nonculprit lesions. The new research shows a strategy of complete revascularization reduces mortality risk and complications. "The newest findings regarding coronary revascularization are great examples of science on the move, and we are responding accordingly," said Dr. Patrick O'Gara, ACC president. Guideline and appropriate use criteria changes could be coming, as well. Healio (free registration)/Cardiology Today's Intervention (9/22), MedPage Today (free registration) (9/23), Medscape (free registration) (9/22)
Share: LinkedInTwitterFacebookGoogle+Email
Female ICs are a minority, data show
Women represented only 4.5% of nearly 10,000 interventional cardiologists practicing from 2009 to 2013, but most work in academic or urban settings, take on complex cases and achieve substantial procedural success. Female interventionalists are employed by a third of U.S. hospitals, and four out of 10 of them are the only female interventionalist at their institution. SCAI trustee Dr. Cindy Grines presented the findings on behalf of SCAI's Women in Innovations. (9/16), Medscape (free registration) (9/16)
Share: LinkedInTwitterFacebookGoogle+Email
The VEINS: Premier National Venous Meeting, October 9-12
The VEINS, Venous Endovascular Interventional Strategies, meeting provides attendees with the tools needed to develop and refine their venous practice. Interventional cardiologists, surgeons, radiologists, internists, fellows-in-training, nurses, and technologists are all welcome to attend and benefit from the multidisciplinary faculty. Click here to learn more.
Policy & Professional News
Improving radiation safety in the cath lab
Medical physicists have a distinct perspective that can help improve radiation safety, but first they need to be allowed into the cath lab to observe procedures, medical physicist Stephen Balter told clinicians at the Transcatheter Cardiovascular Therapeutics meeting. He and other experts discussed the problems associated with current protective gear as well as new technologies that may offer better protection. SCAI President Dr. Charles Chambers stressed the importance of education, training and safety standards. (9/21)
Share: LinkedInTwitterFacebookGoogle+Email
Effort to address medical licensing across state lines gains traction
Fifteen state medical boards are looking at endorsing the Interstate Medical Licensure Compact, designed to streamline licensing across state lines, according to Federation of State Medical Boards President and CEO Dr. Humayun Chaudhry. Goals of the effort include supporting telemedicine and providing a solution to provider shortages and increased patient demand for care. HealthLeaders Media (9/17)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Medical Developments
Google Glass shows promise as an aid to interventionalists
Google Glass can be used in the cath lab to transmit case data in real time, but in the future, it also may provide interventionalists with a patient's vital signs, calculations of left ventricular ejection fraction -- even suggested stent sizes. "I definitely think wearables will be in our future, both for physicians and for patients," said Dr. Jordan Safirstein, who demonstrated Google Glass at the Transcatheter Cardiovascular Therapeutics meeting. (9/16)
Share: LinkedInTwitterFacebookGoogle+Email
Study parses TAVR periprocedural complication costs
More than $10,000 in costs associated with transcatheter aortic valve replacement can be attributed to periprocedural complications, according to an analysis of 506 patients with severe aortic stenosis who participated in the CoreValve extreme risk trial. The authors suggest targeting the complications of most concern could improve TAVR economics. (9/16)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
SCAI names new executive director
SCAI has named Lisa Olson, Ph.D, as its new executive director. Dr. Olson brings deep experience in the cardiovascular field and a vision for continuing to advance SCAI's mission. She joins SCAI from consulting firm aha Group, which she launched in 1999 to provide strategic marketing, market research, development and business planning to medical organizations. Previously, Dr. Olson served as executive director of the Cheney Cardiovascular Institute at George Washington University, the founding executive director of the Heart Rhythm Foundation and an associate executive vice president for the American College of Cardiology. Dr. Olson will join the SCAI team in October. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
Start planning now to attend SCAI 2015 in sunny San Diego
If you can only attend one Interventional Cardiology education meeting in 2015, shouldn't it be the Best of the Best? Shouldn't it be SCAI 2015 Scientific Sessions, taking place in San Diego on May 6-9, 2015? Download the preliminary program, and begin making your plans to join Interventional and Invasive Cardiology at the Hilton Bayfront, just steps away from some of San Diego's greatest attractions. Don't wait -- enroll now!
Share: LinkedInTwitterFacebookGoogle+Email
Art is a marriage of the conscious and the unconscious."
-- Jean Cocteau,
French writer
Share: LinkedInTwitterFacebookGoogle+Email
The news summaries appearing in SCAI SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI SmartBrief constitute the official opinion of SCAI.
The SCAI SmartBrief news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI SmartBrief may be directed to SmartBrief at
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Melissa Turner
Advertising:  Wynn Hansen
  P: 202.470.1149

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information